Industry Symposia


MONDAY 19 AUGUST

Pfizer Breakfast Symposium 

Date: Monday 19th August 

Time: 7.15am to 8.30am (breakfast served from 7:00am)

Title: Managing Growth Hormone deficiency during the transition period - paediatric and adult endocrinologists’ perspective

Presenters: Professor Margaret Zacharin and Associate Professor Ken Ho

This Breakfast Session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by Pfizerlogo19

 


 

Eisai Breakfast Symposium 

Date: Monday 19th August 

Time: 7.00am to 8.00am (breakfast served from 6:45am)

Title: When the 'good cancer' is 'not-so-good' - RAI-R Thyroid Cancer Case Discussion

Content: Differentiated Thyroid Cancer has been described as the ‘good cancer’ because of its overall relatively slow progression when compared to other cancers. However when patients become refractory to radioactive iodine their prognosis changes and may be ‘not-so-good’, and their treatment course is not always straightforward. This symposium will present real patient cases and engage the panel and audience in discussing challenges as well as appropriate treatment strategies.

Presenter: Prof Bruce Robinson, Dr Lori Wirth (international speaker), Prof Duncan Topliss 

Chair: A/Prof Rory Clifton-Bligh

This Breakfast Session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised byEisailogo4 

 

 


Reproductive Health Australia Breakfast Symposium 

Date: Monday 19th August 

Time: 7.30am to 8.30am (breakfast served from 7:15am)

Title: What can Reproductive Health Australia do for you? 

Content: 
What are my research objectives?
How am I achieving those objectives?
What can RHA do for my research?
Followed by 20 minute general discussion

Topic 1: Frontiers in fertility preservation for girls and women with cancer
Topic 2: Assisted reproduction in agricultural animals

Presenter: Dr Karla Hutt & A/Prof Simon de Graaf

Chair: Dr Sarah Meachem & Dr Liza O’Donnell  

This Breakfast Session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised byRHA Logo


TUESDAY 20 AUGUST

iNova Breakfast Symposium

Date: Tuesday 20th August 

Time: 7.00am to 8.15am (breakfast served from 7:00am)

Title: A new pharmacological approach to obesity management - Changing the landscape of obesity management in Australia

Content: 

This session will discuss management of obesity in Australian endocrine practice. Utilization of the current obesity and diabetes treatment algorithms will form the basis of a discussion regarding the effectiveness of obesity treatment at this time point, and what changes need to be considered for the future in order to address the growing epidemic of this disease. Further, a novel combination of pharmacological agents which has recently been approved for management of obesity in Australia (naltrexone/bupropion) will be introduced, highlighting the mode of action, clinical data and where it fits into the landscape of obesity management in this country.

Presenters: 

Professor Stephen Colagiuri
Professor of Metabolic Health and Director of The Boden Institute at The University of Sydney

Professor Michael Cowley
Professor & Chairman, Department of Physiology, Biomedicine Discovery Institute, Monash University, Victoria 

Associate Professor Samantha Hocking
Royal Prince Alfred Hospital, University of Sydney

Chair: 
Professor Stephen Colagiuri

This Breakfast Session is complimentary, however you must sign up for it via your conference registration here

This session is supported and organised by  iNOVA ESA

 

Ipsen Breakfast Symposium

Date: Tuesday 20th August 

Time: 6.45am to 8.15am (breakfast served from 6:45am)

Title: Towards biochemical cure in Acromegaly: is close enough good enough? Insights from clinicians and nurses

Content: 

Achieving a ‘normal’ IGF-1/GH in the medical management of Acromegaly can be difficult to achieve. Local clinicians to discuss the pro’s and cons in striving to achieve a ‘normal’ IGF-1/GH. Addressing questions such as; What is normal IGF-1/GH? What are the clinical impacts? If IGF-1/GH levels are close enough to normal is that good enough if patients feel well? What does this mean for management with SSA’s?  Daphne Adelman, an international Endocrinology Nurse Practioner, will also give insight into patient impact of living with Acromegaly, patient outcomes and QOL.

Presenters:
Dr Ann McCormack
Staff Specialist- Department of Endocrinology St Vincent’s Hospital
Group Leader- Hormones and Cancer, Garvan Institute of Medical Research

Associate Professor Chris Yates
Endocrinologist & Stream Leader Pituitary and Neuroendocrine Tumours
Deputy Head of Bone and Mineral Medicine, Royal Melbourne Hospital Endocrinologist
Director of Endocrine Research, Western Health Honorary Clinical Associate Professor, The University of Melbourne

Dr Mark McClean
Divisional Director – Ambulatory Medicine
Staff Specialist in Diabetes and Endocrinology – Blacktown and Westmead Hospitals
Chair – Medical Staff Council for BMDH
Conjoint Professor of Medicine – Western Sydney University

Ms Daphne Adelman
Clinical Nurse Specialist and Research Study Coordinator
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University, Chicago
Feinberg School of Medicine

Chair:
Dr Ann McCormack

This session is supported and organised by IPSENweb2

 

Novo Nordisk Breakfast Symposium

Date: Tuesday 20th August

Time: 6.45am to 8.00am (breakfast served from 6:45am)

Title: Innovations and Advances in Diabetes Management

Content: A multitude of new treatments for the management of diabetes have emerged over the last decade. In the last year, Novo Nordisk Pharmaceuticals has launched two next-generation insulins; Fiasp® and Ryzodeg® 70/30, in Australia. This symposium will bring together a notable faculty of diabetes experts, who will discuss how beneficial these recent advancements in insulin are, and which patient groups may benefit from these. The faculty will also share their clinical experience with Fiasp® and Ryzodeg® 70/30 via the presentation of four case studies.

Chair: A/Prof Neale Cohen

Topics: Benefits and Advances in Diabetes Management by Prof Greg Fulcher
Case Studies by Prof Greg Fulcher, A/Prof Neale Cohen, A/Prof Jane Overland
Question and Discussion Panel

This session is supported and organised by NOVOwebsite2

 

 

WEDNESDAY 21 AUGUST

Bioscientifica Symposium - Practical Publishing Advice 

Date: Wednesday 21st August 

Time: 1.00pm to 2.00pm (lunch boxes provided for attendees)

Title: Bioscientifica Symposium - Practical Publishing Advice

Content: This workshop aims to provide practical publishing advice to less experienced researchers and provides an opportunity to ask their publishing related questions to members of the editorial board.  This session will focus on various aspects of the publishing journey from what to expect in the peer review process, to responding to reviewers. 

13:00 -  Introduction from the Chair
Sof Andrikopoulos, co-Editor-in-Chief, Journal of Endocrinology and Journal of Molecular Endocrinology

13:10 -  How to write an attention grabbing abstract
Deborah Marsh, Associate Editor, Endocrine-Related Cancer

13:20  - Responding to reviewers
Tim Cole, Associate Editor Journal of Endocrinology and Journal of Molecular Endocrinology

13:30  - Open Access
Jerry Greenfield, co-Editor-in-Chief, Endocrinology, Diabetes and Metabolism Case Reports

13:40 - Increasing the impact of your work
Morag Young, Senior Editor Journal of Endocrinology and Journal of Molecular Endocrinology

15:50 - Questions and discussion

This Lunchtime Session is complimentary, however you must sign up for it via your conference registration here.

This session is supported and organised by Bioscientifica 

  


Our Sponsors